3rd Quarter - Report

INNOVATIVE FEDERAL STRATEGIES, LLC for CERUS CORPORATION

Firm
Client
Income
$40,000
Expenses
—

What was lobbied

3 issue areas, each in the filer's own words, with who lobbied on it and where.

Budget/Appropriations BUD

H.R.9495/S.____ Department of Defense Appropriations Bill, 2027, Title VI, all provisions related to blood safety. H.R.9260/S.____ Departments of Labor, Health and Human Services, Education, and Related Agencies Appropriations bill, 2027 - Title II, all provisions related to blood safety.

LobbyistCovered position, as disclosed
ERYNN D HOOK —
JOSHUA KEY New Deputy COS / Scheduler, Rep. Kay Granger / District Director, Rep. Mayra Flores / Deputy District Director & Constituent Advocate, Rep. Mike Coffman
CARL KIME —
JOSEPH MINGES —
LETITIA WHITE —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 9495 (119th), H.R. 9260 (119th)

Defense DEF

H.R.8800/S.4784 National Defense Authorization Act, 2027, Title XIV, all provisions related to blood safety.

LobbyistCovered position, as disclosed
ERYNN D HOOK —
JOSHUA KEY —
CARL KIME —
JOSEPH MINGES —
LETITIA WHITE —

Bills named: H.R. 8800 (119th), S. 4784 (119th)

Health Issues HCR

Contacted officials regarding the Red Blood Cell Clinical Trial Program and blood safety issues.

LobbyistCovered position, as disclosed
ERYNN D HOOK —
JOSHUA KEY —
CARL KIME —
JOSEPH MINGES —
LETITIA WHITE —

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.